SEC Form 4 · accession 0001567619-18-000418
IDEXX LABORATORIES INC /DE · IDXX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jacqueline Studer
Officer — CVP, Gen. Counsel & Secretary
Period of report
Aug 8, 2018
Accepted (ET)
Aug 10, 2018 · 5:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874716
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 8, 2018 | M | 1,783 | $79.54 | A | 7,632 | D | |
| Common Stock | Aug 8, 2018 | M | 2 | $67.85 | A | 7,634 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right-to-buy)F3,F1 | $79.54 | Aug 8, 2018 | M | 1,783 | D | — | Feb 13, 2025 | Common Stock | 1,783 | 2,512 | D |
| Incentive Stock Option (right-to-buy)F3,F2 | $67.85 | Aug 8, 2018 | M | 2 | D | — | Feb 13, 2026 | Common Stock | 2 | 1,475 | D |
Explanation of responses
- F1Grant of option to buy 3,140 shares of Issuer common stock that vests and is exercisable in five equal annual installments beginning on February 14, 2016, without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
- F2Grant of option to buy shares of Issuer common stock exercisable in five annual installments beginning February 14, 2017.
- F3Not applicable.